Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Hepatic Function and Subjects With Moderate Hepatic Impairment [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing hydrocodone extended-release CEP-33237 in subjects with normal hepatic function and those with moderate hepatic impairme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• CEP-33237 Hydrocodone Extended-Release Tablet (hydrocodone extended-release tablet)

Snippet

Sponsor: Cephalon | Conditions: Hepatic Impairment | Phase 1 | Status: COMPLETED